CHRISTIE BALLANTYNE to Hyperlipoproteinemia Type I
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Hyperlipoproteinemia Type I.
Connection Strength
2.753
-
Epidemiology and longitudinal course of chylomicronemia: Insights from NHANES and a large health care system. J Clin Lipidol. 2025 May-Jun; 19(3):432-441.
Score: 0.935
-
Recognition and management of persistent chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2025 Jul-Aug; 19(4):723-736.
Score: 0.935
-
An overview of persistent chylomicronemia: much more than meets the eye. Curr Opin Endocrinol Diabetes Obes. 2025 Apr 01; 32(2):75-88.
Score: 0.232
-
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA. Atherosclerosis. 2025 04; 403:119114.
Score: 0.231
-
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome. N Engl J Med. 2024 05 16; 390(19):1781-1792.
Score: 0.218
-
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nat Med. 2023 03; 29(3):729-737.
Score: 0.203